Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |